Target intelligence / Profile preview

Protein SCO1 homolog, mitochondrial (SCO1)

Target
SCO1
Molecular classification
Enzyme assembly factor, Mitochondrial protein, Copper metallochaperone, Single-pass membrane protein
01

Overview

Protein SCO1 homolog, mitochondrial (SCO1) is a copper metallochaperone essential for the assembly and maturation of cytochrome c oxidase subunit II (COX2 or MT-CO2) in the mitochondrial respiratory chain. It is embedded in the inner mitochondrial membrane, where it facilitates copper delivery to the enzyme complex required for efficient electron transfer and ATP synthesis via oxidative phosphorylation. SCO1 is crucial for copper homeostasis and redox balance in cells with high metabolic demand. Mutations in SCO1 result in tissue-specific mitochondrial complex IV deficiencies manifesting as severe, often fatal, multisystem disorders including hepatic failure, cardiomyopathy, and encephalopathy. SCO1 interacts directly with other COX assembly factors and is part of a conserved mitochondrial copper delivery pathway

Other names
SCO1Synthesis of cytochrome c oxidase 1SCO1, cytochrome c oxidase assembly proteinSCOD1MC4DN4SCO cytochrome c oxidase assembly protein 1SCO cytochrome oxidase deficient homolog 1
02

Mechanism of action

Molecules that target or modulate SCO1 would likely affect the assembly/stability of cytochrome c oxidase, copper delivery, or mitochondrial electron transport

03

Biological functions

Assembly of cytochrome c oxidase (Complex IV) in mitochondrial respiratory chainCopper ion transport and homeostasisRegulation of mitochondrial oxidative phosphorylationCellular redox signaling
04

Disease associations

Mitochondrial complex IV deficiencyHepatic failureEncephalopathyHypertrophic cardiomyopathyLeigh syndromeSevere infantile multisystem disease
05

Safety considerations

SCO1 modulation could disrupt mitochondrial respiration, leading to lactic acidosis, multiorgan dysfunction, and fatal encephalopathy if improperly targeted
06

Interacting drugs

None documented as direct clinical drugs; copper modulation may be experimentally relevant
07

Biomarkers

SCO1 gene mutations (e.g., P174L, M294V) as genetic markers for mitochondrial complex IV deficiency and related encephalopathiesCytochrome c oxidase activity levels for functional diagnosis

Beyond the preview

Go deeper on Protein SCO1 homolog, mitochondrial (SCO1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein SCO1 homolog, mitochondrial (SCO1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call